Hosted on MSN23d
Legend Biotech stock target cut to $91 by JefferiesOn Wednesday, Jefferies maintained its Buy rating on Legend Biotech Corp . (NASDAQ:LEGN) but reduced the stock's price target ... performance of Carvykti, a CAR-T therapy, is characterized by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback